{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:02:54Z","timestamp":1762506174502,"version":"3.41.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/igc.0b013e3182a26edb","type":"journal-article","created":{"date-parts":[[2013,9,14]],"date-time":"2013-09-14T09:47:50Z","timestamp":1379152070000},"page":"1528-1534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting"],"prefix":"10.1016","volume":"23","author":[{"given":"Carien L.","family":"Creutzberg","sequence":"first","affiliation":[]},{"given":"Henry C.","family":"Kitchener","sequence":"additional","affiliation":[]},{"given":"Michael J.","family":"Birrer","sequence":"additional","affiliation":[]},{"given":"Fabio","family":"Landoni","sequence":"additional","affiliation":[]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[]},{"given":"Melanie","family":"Powell","sequence":"additional","affiliation":[]},{"given":"Carol","family":"Aghajanian","sequence":"additional","affiliation":[]},{"given":"Richard","family":"Edmondson","sequence":"additional","affiliation":[]},{"given":"Paul J.","family":"Goodfellow","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Quinn","sequence":"additional","affiliation":[]},{"given":"Helga B.","family":"Salvesen","sequence":"additional","affiliation":[]},{"given":"Gillian","family":"Thomas","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e3182a26edb_bb0005","first-page":"220","article-title":"Cancer treatment and survivorship statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"author":"WHO Cancer Mondial. GLOBOCAN. International Association of Cancer Registries (IACR)","key":"10.1097\/IGC.0b013e3182a26edb_bb0010"},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/IGC.0b013e3181995f90","article-title":"Endometrial cancer state of the science meeting","volume":"19","author":"Kitchener","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0020","article-title":"consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)","author":"du Bois","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0025","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/IGC.0b013e31821b2568","article-title":"2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference","volume":"21","author":"Stuart","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0030","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/IGC.0b013e3181e730aa","article-title":"The development of priority cervical cancer trials: a Gynecologic Cancer InterGroup report","volume":"20","author":"Kitchener","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0040","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial","volume":"100","author":"Benedetti","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jjco\/hys019","article-title":"Systematic lymphadenectomy for survival in patients with endometrial cancer: a meta-analysis","volume":"42","author":"Kim","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0050","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ygyno.2011.08.034","article-title":"Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies","volume":"123","author":"Kang","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0055","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/IGC.0b013e318230c264","article-title":"Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate-and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy","volume":"22","author":"Narayan","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0060","unstructured":"KGOG-2015 trial. Available at: http:\/\/clinicaltrials.gov\/show\/NCT01527396. Accessed May 14, 2013."},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0065","unstructured":"PORTEC-3 trial. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00411138. Accessed May 14, 2013."},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0070","unstructured":"GOG#249 trial. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00807768. Accessed May 14, 2013."},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0075","unstructured":"GOG#258 trial. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00942357. Accessed May 14, 2013."},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0080","unstructured":"ENGOT-EN2-DGCG trial. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01244789. Accessed May 14, 2013."},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0085","unstructured":"PORTEC-4 trial. Available at: http:\/\/www.trialregister.nl\/trialreg\/admin\/rctview.asp?TC=3263Accessed May 14, 2013."},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0095","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancerYresults from two randomised studies","volume":"46","author":"Hogberg","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0100","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ejca.2008.01.019","article-title":"Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: a European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)","volume":"44","author":"Reed","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0105","unstructured":"GOG#261 trial. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00954174. Accessed May 14, 2013."},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0115","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2009.06.011","article-title":"Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review","volume":"115","author":"Boruta","year":"2009","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrclinonc.2010.216","article-title":"Emerging therapeutic targets in endometrial cancer","volume":"8","author":"Dedes","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ygyno.2007.04.032","article-title":"The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study","volume":"106","author":"McMeekin","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0130","article-title":"A phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma [abstract]","volume":"29: Abstract 5012","author":"Slomovitz","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0135","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/S1470-2045(12)70213-9","article-title":"Markers for individualised therapy in endometrial carcinoma","volume":"13","author":"Salvesen","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0140","unstructured":"GOG#210. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00340808. Accessed May 14, 2013."},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0145","unstructured":"MoMaTEC. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00598845. Accessed May 14, 2013."},{"key":"10.1097\/IGC.0b013e3182a26edb_bb0150","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/IGC.0b013e31820575f5","article-title":"Evolution in endometrial cancer: evidence from an immunohistochemical study","volume":"21","author":"Vandenput","year":"2011","journal-title":"Int J Gynecol Cancer."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24030755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24030755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:36:27Z","timestamp":1753101387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24030755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1048891X24030755"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e3182a26edb","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e3182a26edb","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2013 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}